Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|June 2, 2017

Advancements in Asthma Therapy and Their Impact on Managed Care

Click Here to Complete this CE Activity

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Hematology lab comparing blood samples | Image Credit: © NanSan - stock.adobe.com

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

ByChristina Mattina

June 14th 2026

Holding a globe with interconnected nodes | Image Credit: © vegefox.com - stock.adobe.com

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

ByChristina Mattina

June 13th 2026

Debate stage podiums | Image Credit: © Aliaksandr Marko - stock.adobe.com

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

ByChristina Mattina

June 13th 2026

Health Equity & Access Weekly Roundup

Health Equity & Access Weekly Roundup: June 12, 2026

ByGiuliana Grossi

June 12th 2026

Baltimore | Image credit: Kevin Ruck - stock.adobe.com

Sleep Conference Promises Focus on OSA, Artificial Intelligence in Annual Meeting

ByJulia Bonavitacola

June 12th 2026

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD